RecruitingNCT05144633

Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

Sponsor

University of Louisville

Enrollment

100 participants

Start Date

Sep 9, 2021

Study Type

OBSERVATIONAL

Conditions

Acute Respiratory Failure

Summary

This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria3

Adults aged 18 years or older presenting to the ED or admitted to the hospital within 12 hours of enrollment
Acute respiratory failure defined as new onset shortness of breath initiated within the last 7 days, and new or increasing need for oxygen therapy
The patient or patient's legal health care proxy consents to participation

Exclusion Criteria5

Unwillingness to consent
Patients with trauma as the cause of ARF
Patients with pneumothorax as the cause of ARF
Inability to perform pulmonary POCUS or lung auscultation (e.g. dressing on the chest)
Unwilling or unable to complete the minimum of 12 lung sound stethoscope recordings.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAuscultation

This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.